As well as the key themes of skills, innovation, biorefining and industry engagement, the new updated National Plan also makes public engagement a top priority.
The launch took place at the Industrial Biotechnology Innovation Centre’s (IBioIC) fifth Annual Conference in Glasgow, which continues to be the largest IB conference in the UK, attracting an audience of over 450 local and international delegates from industry and academia.
The IB sector makes an important contribution to the Scottish economy, whilst also reducing our impact on the environment.
By using plant-based sources to produce or process materials, chemicals or energy, IB has the potential to address some of the world’s biggest challenges by offering green alternatives to fossil fuels.
When the National Plan was initially published by the Scottish Industrial Biotechnology Development Group (SIBDG) in 2013, it set out an ambitious target for the IB sector to reach 200 companies and a £900 million turnover by 2025.
The industry is on course to meet these targets, having grown from 43 to over 110 companies with an additional 170 jobs created, and a compound annual growth rate of 10 per cent to over £340 million per annum.
A key reason for this success has been the establishment of IBioIC in 2014, which has quickly been recognised as a European centre of excellence for industry-led research, having supported 48 industry/academia collaborative projects with an accumulated value of £14 million.
In August 2018, IBioIC received £11m of core funding for a further five years to continue supporting the rapidly growing IB industry.
Roger Kilburn, Chair of the Scottish IB Development Group, said: “The updated National Plan will be IBioIC’s key roadmap for the next five years, and our goals align closely with it. The IB industry in Scotland has strong foundations and has grown significantly over the past five years, but we need to aim even higher.
“Scotland is perfectly placed to become a world leader in industrial biotechnology – we have a highly skilled workforce, well-established IB companies of all sizes who are pursuing aggressive growth, and a unique wealth of relevant natural resources such as algae, agricultural waste and forestry.
“Biotechnology is a positive innovation for Scotland. It is replacing existing pharmaceuticals, chemicals and fuels with sustainable, non-fossil-based alternatives. But that positive message isn’t getting out there to the general public – so I welcome the fact that along with skills, innovation, biorefining and industry engagement, the new updated National Plan also makes public engagement a priority.”
Ivan McKee MSP, Minister for Trade, Investment and Innovation said: “Scotland’s economic strategy prioritises boosting investment and innovation to create a strong vibrant and sustainable economy.
“Given Scotland is a world leader in circular economy, the transformative technologies offered by industrial biotechnology further supports this by using innovative processes and sustainable raw materials with a reduced carbon footprint.
“I believe the industrial biotechnology industry in Scotland will continue to make a strong contribution to our economy, whilst also reducing our impact on the environment. The targets in this plan are ambitious but ambition is the first step to success.”
Julia Brown, director of Life and Chemical Sciences at Scottish Enterprise said: “Scottish Enterprise recognises the key role that industrial biotechnology plays in the future of sustainable manufacturing in Scotland. This technology will bring a positive impact to the Scottish economy by creating jobs and decreasing Scotland’s dependency on fossil fuels, helping us move towards a cleaner, greener future.
“We have demonstrated our commitment to the continued growth of this industry by core funding the IBioIC for 5 years to support this rapidly growing field and to achieve the ambitious targets set out in the National Plan.”